The rate of cognitive decline in Parkinson disease.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 1.83

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One (2010) 1.72

Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.59

Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain (2011) 1.55

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49

Epidemiology of Parkinson's disease. J Neurol (2008) 1.38

A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord (2010) 1.13

Genetic influences on cognitive decline in Parkinson's disease. Mov Disord (2012) 1.10

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol (2014) 1.07

Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm (Vienna) (2011) 1.04

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. Front Neurol (2012) 0.98

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Mov Disord (2015) 0.94

Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Brain (2009) 0.92

Psychiatric issues in cognitive impairment. Mov Disord (2014) 0.91

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Front Behav Neurosci (2014) 0.87

Cognitive profile of LRRK2-related Parkinson's disease. Mov Disord (2015) 0.87

Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study. J Neurol (2012) 0.87

Executive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performance. PLoS One (2011) 0.83

Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm (Vienna) (2014) 0.83

Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach. Int J Alzheimers Dis (2012) 0.79

MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Neural Transm (Vienna) (2016) 0.78

Predictors of cognitive decline in the early stages of Parkinson's disease: a brief cognitive assessment longitudinal study. Parkinsons Dis (2013) 0.78

How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study. J Neurol (2009) 0.77

New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges. Parkinsons Dis (2011) 0.76

Resveratrol Protects PC12 Cell against 6-OHDA Damage via CXCR4 Signaling Pathway. Evid Based Complement Alternat Med (2015) 0.76

Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia. PLoS One (2013) 0.75

Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting. PLoS One (2016) 0.75

Capgras delusion for animals and inanimate objects in Parkinson's Disease: a case report. BMC Psychiatry (2015) 0.75

Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons. Sci Rep (2017) 0.75

A randomized controlled trial of an enhanced interdisciplinary community based group program for people with Parkinson's disease: study rationale and protocol. Neurol Int (2012) 0.75

Event-Related Potentials in Parkinson's Disease Patients with Visual Hallucination. Parkinsons Dis (2016) 0.75

Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease. Neurol Med Chir (Tokyo) (2014) 0.75

Visual Hallucinations and Amyloid Deposition in Parkinson's Disease Dementia: A Case Report. Psychiatry Investig (2016) 0.75

Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most? J Neural Transm (Vienna) (2011) 0.75

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease. Neurobiol Aging (2017) 0.75

Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal. J Neural Transm (Vienna) (2017) 0.75

Therapy-resistant symptoms in Parkinson's disease. J Neural Transm (Vienna) (2015) 0.75

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol (2003) 4.76

Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol (2005) 3.31

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96

Predictors of mortality in 2,249 nonagenarians--the Danish 1905-Cohort Survey. J Am Geriatr Soc (2003) 2.79

Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47

Frontotemporal dementia in elderly individuals. Arch Neurol (2012) 2.21

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol (2013) 2.19

Endovascular acute stroke treatment performed by vascular interventional radiologists: is it safe and efficacious? Cardiovasc Intervent Radiol (2012) 2.06

[Alcohol use disorders in elderly people calls for treatment]. Ugeskr Laeger (2014) 1.98

Paternity following treatment for testicular cancer. J Natl Cancer Inst (2005) 1.87

Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord (2013) 1.74

Post-traumatic stress reactions in survivors of the 2011 massacre on Utøya Island, Norway. Br J Psychiatry (2013) 1.73

A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66

Growth of untreated vestibular schwannoma: a prospective study. J Neurosurg (2012) 1.66

Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54

Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer (2009) 1.52

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry (2007) 1.52

Factors complicating interpretation of capnography during advanced life support in cardiac arrest--a clinical retrospective study in 575 patients. Resuscitation (2012) 1.50

Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia (2011) 1.50

Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion (2009) 1.50

Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes (2004) 1.48

Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48

The other side of the coin: perceived positive effects of illness in women following acute myocardial infarction. Eur J Cardiovasc Nurs (2007) 1.48

Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis (2005) 1.45

Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43

Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol (2010) 1.43

[Alcohol use disorders in elderly people calls for treatment]. Ugeskr Laeger (2015) 1.40

Epidemiology of Parkinson's disease. J Neurol (2008) 1.38

Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord (2008) 1.33

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol Aging (2012) 1.31

Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry (2004) 1.31

Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31

Burnout in medical students: a systematic review. Clin Teach (2013) 1.30

The coping styles of adolescents with type 1 diabetes are associated with degree of metabolic control. Diabetes Care (2004) 1.28

Estimating the burden of malaria in Senegal: Bayesian zero-inflated binomial geostatistical modeling of the MIS 2008 data. PLoS One (2012) 1.28

The day Norway cried: Proximity and distress in Norwegian citizens following the 22nd July 2011 terrorist attacks in Oslo and on Utøya Island. Eur J Psychotraumatol (2012) 1.24

Depression and the risk of Alzheimer disease. Epidemiology (2005) 1.23

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22

Identification of novel and improved antimitotic agents derived from noscapine. J Med Chem (2005) 1.20

Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol (2010) 1.19

Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry (2009) 1.19

Reduced white matter connectivity in the corpus callosum of children with Tourette syndrome. J Child Psychol Psychiatry (2006) 1.16

Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud (2011) 1.16

Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery (2005) 1.16

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry (2010) 1.16

Associations between sleep problems and attentional and behavioral functioning in children with anxiety disorders and ADHD. Behav Sleep Med (2013) 1.15

Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal. Malar J (2012) 1.13

Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care (2007) 1.13

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis (2010) 1.12

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry (2005) 1.11

Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med (2007) 1.10

Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol (2004) 1.09

Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord (2008) 1.08

Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia (2003) 1.08

Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys (2007) 1.08

Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06

Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord (2006) 1.06

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord (2005) 1.05

The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci (2010) 1.05

Perceived family burden and emotional distress: similarities and differences between mothers and fathers of children with type 1 diabetes in a population-based study. Pediatr Diabetes (2011) 1.04

High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study. World J Surg Oncol (2010) 1.04

Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. J Natl Cancer Inst (2009) 1.04

Long-term mental health of Vietnamese refugees in the aftermath of trauma. Br J Psychiatry (2010) 1.04

Altered neurogenesis in Alzheimer's disease. J Psychosom Res (2006) 1.03

Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. Infect Immun (2010) 1.02

Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry (2003) 1.02

Health-related quality of life and metabolic control in adolescents with diabetes: the role of parental care, control, and involvement. J Pediatr Nurs (2005) 1.02

Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci (2002) 1.01

A randomized effectiveness study comparing trauma-focused cognitive behavioral therapy with therapy as usual for youth. J Clin Child Adolesc Psychol (2013) 1.01

Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J (2010) 1.00

Patient-reported outcomes as predictors of 10-year survival in women after acute myocardial infarction. Health Qual Life Outcomes (2010) 1.00

Mental health problems in the 10th grade and non-completion of upper secondary school: the mediating role of grades in a population-based longitudinal study. BMC Public Health (2014) 1.00

Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord (2010) 0.99

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. J Geriatr Psychiatry Neurol (2009) 0.97

Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin Biol Ther (2007) 0.97

A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord (2003) 0.97

Posttraumatic growth, depressive symptoms, posttraumatic stress symptoms, post-migration stressors and quality of life in multi-traumatized psychiatric outpatients with a refugee background in Norway. Health Qual Life Outcomes (2012) 0.97

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival. J Urol (2009) 0.96

Mental health problems and post-migration stress among multi-traumatized refugees attending outpatient clinics upon resettlement to Norway. Scand J Psychol (2012) 0.96

Cost of dementia: impact of disease progression estimated in longitudinal data. Scand J Public Health (2003) 0.96

Suicide risk and acute psychiatric readmissions: a prospective cohort study. Psychiatr Serv (2010) 0.95

The Norwegian version of the PTSD Checklist (PCL): construct validity in a community sample of 2004 tsunami survivors. Nord J Psychiatry (2012) 0.94

FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study. J Geriatr Psychiatry Neurol (2007) 0.94

Dementia with Lewy bodies. Semin Clin Neuropsychiatry (2003) 0.94